Ilmodol Dolore E Infiammazione (Piroxicam)

Piroxicam works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, the drug diminishes the inflammatory cascade, leading to reduced pain signaling, swelling, and redness at the site of application.

The appropriate dose and frequency of Ilmodol Dolore E Infiammazione are determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for topical piroxicam in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Ilmodol Dolore E Infiammazione (piroxicam) offers a longer half‑life than many topical NSAIDs such as diclofenac, allowing once‑ or twice‑daily application for sustained relief. Its potency in inhibiting both COX‑1 and COX‑2 can provide effective anti‑inflammatory action, though individual response and tolerability may vary, making a clinician‑guided choice important.

Store the product at room temperature, ideally below 25 °C, in its original packaging. Keep it away from excessive moisture, direct sunlight, and heat sources. Ensure the container is tightly closed after each use to maintain product stability.

Apply a thin layer of the gel or cream to the clean, dry skin over the affected area, typically 2–4 g depending on the size of the region. Gently rub it in until fully absorbed. Frequency and duration of use should follow the prescriber’s guidance, usually not exceeding the recommended daily total amount.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis. Systemic absorption may lead to gastrointestinal bleeding, renal impairment, or hepatic toxicity, especially when used with other NSAIDs or anticoagulants. Patients should seek immediate medical attention if they notice widespread rash, blistering, or signs of bleeding.

Individuals with known hypersensitivity to piroxicam or any component of the formulation should avoid use. It is also contraindicated on broken, infected, or severely inflamed skin, in patients with severe liver or kidney disease, and in children unless specifically prescribed. Consultation with a healthcare professional is essential before starting therapy.